EU-V: U32 Kommunikationsdokument
Draft REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or prevent coronavirus disease [2020/0128 (COD)] Outcome of the written procedure initiated by CM 3031/20: – Adoption of the legislative act, and – Derogation from the 8-week period provided for in Article 4 of Protocol 1 to the TFEU on the role of national parliaments in the EU
Erstellt am 14.07.2020 von: Interinstitutionelle Beziehungen
Eingelangt am 14.07.2020, U32 Übermittlung
- RAT: CM 3072/20 PDF
Linkart | Link |
---|---|
COM
Kommission |
COM(2020) 261 |
INT
Interinstitutionelle Zahl |
2020/0128 (COD) |
RAT
Rat |
CM 3031/20 |
Interinstitutionelle Zahl
Der Link führt zu den einzelnen Dokumenten dieses Vorhabens. |
Link |
---|---|
2020/0128 COD | Legislative Observatory |
Code | Sachgebiet |
---|---|
CODEC | Mitentscheidungsverfahren |
PHARM | Pharmazie |
SAN | Gesundheit |
MI | Binnenmarkt |
COMPET | Wettbewerbsfähigkeit (Binnenmarkt/Industrie) |
AGRILEG | Agrarpolitik: Harmonisierung der Rechtsvorschriften |
ENV | Umwelt |
PROCED | Schriftliches Verfahren |